| |
Jpn J Pharmacol, Vol. 71, No. 1. (May 1996), pp. 81-84.
|
| |
Eur J Pharmacol, Vol. 341, No. 1. (2 January 1998), pp. 33-37.
|
| |
Pharm Res, Vol. 12, No. 1. (January 1995), pp. 18-23.
|
| |
Pharm Res, Vol. 12, No. 12. (December 1995), pp. 1973-1979.
|
| |
Nucl Med Biol, Vol. 23, No. 6. (August 1996), pp. 753-759.
|
| |
Nucl Med Biol, Vol. 23, No. 6. (August 1996), pp. 821-826.
by M. Haruno, M. Kuroki, K. Matsunaga, et al.J. Takata, Y. Karube, T. Senba, M. Murakami, F. Arakawa, M. Kuwahara, H. Ozaki, Y. Matsuoka, M. Okazaki, H. Kanda
|
| |
Biol Pharm Bull, Vol. 22, No. 2. (February 1999), pp. 172-178.
|
| |
Ann Nucl Med, Vol. 13, No. 6. (December 1999), pp. 407-413.
|
| |
Biol Pharm Bull, Vol. 22, No. 12. (December 1999), pp. 1347-1354.
|
| |
Toxicology, Vol. 180, No. 2. (15 November 2002), pp. 183-193.
|
| |
J Lipid Res, Vol. 43, No. 12. (December 2002), pp. 2196-2204.
|
| |
Neurosci Lett, Vol. 337, No. 1. (30 January 2003), pp. 56-60.
|
| |
Biol Pharm Bull, Vol. 28, No. 1. (January 2005), pp. 173-175.
by M. Yoshida, M. Fuchigami, T. Nagao, et al.H. Okabe, K. Matsunaga, J. Takata, Y. Karube, R. Tsuchihashi, J. Kinjo, K. Mihashi, T. Fujioka
|
| |
Biol Pharm Bull, Vol. 26, No. 11. (November 2003), pp. 1523-1527.
|
| |
Eur J Pharmacol, Vol. 350, No. 2-3. (5 June 1998), pp. 165-169.
|
| |
Nucl Med Biol, Vol. 32, No. 3. (April 2005), pp. 279-285.
|